Navigation Links
Anesthesia Drugs Market to Grow to $4.3 Billion by 2011 as Populations and Uses for Anesthesia Increase

NEW YORK, Oct. 12 /PRNewswire/ -- New products, a growing world population expected to reach 6.8 billion in three years, as well as the aging of that population, will push anesthesia drug sales 1.9% to nearly $4.3 billion by 2011, according to Anesthesia Drugs: Worldwide Markets, a new report by Kalorama Information.

More than 300 million surgical procedures required anesthetic administration worldwide in 2006, and Kalorama Information expects that number will rise accordingly as the incidence and prevalence of disease grows with the world population.

Adjunctive therapies, drugs given in the perioperative period to facilitate and/or augment the anesthetic process, will likely represent the largest percentage of growth during the forecast period primarily due to new developments in the anesthesia reversal market. The adjunctive therapies market grew from $793.3 million in 2004 to $825.5 million in 2006 and is expected to reach $1.2 billion by 2011, an increase of 8.2%.

Trends affecting future growth of anesthesia drugs include research and development in several promising areas, including the treatment of depression and sleep disorders and the growing use of conscious sedation, a procedure that involves sedative drugs that lower the level of consciousness but doesn't put a patient completely under.

"The availability of sedating drugs, such as fentanyl and Versed, has been a real boon to the industry," said Melissa Elder, author of Anesthesia Drugs. "Advancements in the area of conscious sedation have resulted in nearly 70% of surgical procedures being performed in hospital outpatient departments, surgical centers, and doctor's offices, which allow doctors to perform operations ranging from tummy tucks to cardiac catheterizations without the need for general anesthesia or an overnight hospital stay."

Anesthesia Drugs covers both currently marketed and late stage development anesthesia drugs worldwide with special emphasis on general, local, and adjunctive therapies in anesthesia in the U.S. The report analyzes products in development and on the market, leading competitors, and current issues and trends affecting the industry. This report can be purchased directly from Kalorama Information by visiting It is also available at

About Kalorama Information

Kalorama Information, a division of, supplies the latest in independent market research on medical markets. For more information, contact Tom Ehart at 240-747-3014 or, or visit

SOURCE Kalorama Information
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Bypass Heart Surgery Performed Without General Anesthesia
2. General Anesthesia Safe For Children On Ketogenic Diet Suffering From Epilepsy
3. General Anesthesia For Heroin Detoxification Is No Good
4. Anesthesia Drug To Bring Solace To The Depressed
5. Choice of Anesthesia in C-section
6. Dental Researchers Test No-Needle Anesthesia, No-Drilling Cavity Care
7. Targeted Anesthesia Can Minimize Pain During Prostate Biopsy
8. Obstetrical Anesthesia Equally Safe When Provided by CRNAs or Anesthesiologists
9. Two New Anesthesia Positions Promise to Ease Surgery Queue
10. Lean Protein Could Be Key to Obesity Drugs
11. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
Post Your Comments:
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: